Kane Biotech Receives Health Canada Approval for revyve(R) Antimicrobial Wound Gel Spray
Kane Biotech Receives Health Canada Approval for revyve(R) Antimicrobial Wound Gel Spray GlobeNewswire December 10, 2025 WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve(R) Antimicrobial Wound Gel Spray for use in Canada. Health Canada approved revyve […]